Literature DB >> 1986467

The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease.

A Manns1, W A Blattner.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 1986467     DOI: 10.1046/j.1537-2995.1991.31191096189.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  23 in total

1.  Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.

Authors:  W Heneine; R F Khabbaz; R B Lal; J E Kaplan
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

Review 2.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

3.  Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon.

Authors:  HaoQiang Zheng; Nathan D Wolfe; David M Sintasath; Ubald Tamoufe; Matthew Lebreton; Cyrille F Djoko; Joseph Le Doux Diffo; Brian L Pike; Walid Heneine; William M Switzer
Journal:  Virology       Date:  2010-03-30       Impact factor: 3.616

4.  Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

Authors:  R S Garfein; D Vlahov; N Galai; M C Doherty; K E Nelson
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

5.  Inhibition of HTLV-I induction and virus-induced syncytia formation by oligodeoxynucleotides.

Authors:  N Miyano-Kurosaki; Y Koyanagi; M Mizuguchi; S Ohki; K Makino; N Yamamoto
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

6.  Antibodies anti HTLV-I/II in Sicilian residents, in drug addicts, and in African immigrants.

Authors:  S Mansueto; M D Miceli; P Di Blasi; G Alleto; A Amico; S Mancuso; G Gentile
Journal:  Eur J Epidemiol       Date:  1995-06       Impact factor: 8.082

Review 7.  Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

Authors:  Denise Utsch Gonçalves; Fernando Augusto Proietti; João Gabriel Ramos Ribas; Marcelo Grossi Araújo; Sônia Regina Pinheiro; Antônio Carlos Guedes; Anna Bárbara F Carneiro-Proietti
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

8.  Infection with human T-lymphotropic virus types I and II results in alterations of cellular receptors, including the up-modulation of T-cell counterreceptors CD40, CD54, and CD80 (B7-1).

Authors:  C S Dezzutti; D L Rudolph; R B Lal
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

9.  Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type 1 trans activator Tax.

Authors:  S R Himes; R Katsikeros; M F Shannon
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Phenotypic expression of integrin membrane receptors on spontaneously proliferating CD8 cells in human T-lymphotropic virus type II (HTLV-II)-infected individuals.

Authors:  R B Lal; D L Rudolph; T Rowe; T M Folks
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.